ID   VPP2_HUMAN              Reviewed;         856 AA.
AC   Q9Y487; A8K026; Q6NUM0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 2.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=V-type proton ATPase 116 kDa subunit a isoform 2;
DE            Short=V-ATPase 116 kDa isoform a2;
DE   AltName: Full=Lysosomal H(+)-transporting ATPase V0 subunit a2;
DE   AltName: Full=TJ6;
DE   AltName: Full=Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2;
GN   Name=ATP6V0A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Babichev Y., Isakov N.;
RT   "Characterization of human TJ6 homolog.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Astrocyte;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PSCD2.
RX   PubMed=16415858; DOI=10.1038/ncb1348;
RA   Hurtado-Lorenzo A., Skinner M., El Annan J., Futai M., Sun-Wada G.-H.,
RA   Bourgoin S., Casanova J., Wildeman A., Bechoua S., Ausiello D.A.,
RA   Brown D., Marshansky V.;
RT   "V-ATPase interacts with ARNO and Arf6 in early endosomes and
RT   regulates the protein degradative pathway.";
RL   Nat. Cell Biol. 8:124-136(2006).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17295899; DOI=10.1111/j.1600-0897.2006.00463.x;
RA   Ntrivalas E., Gilman-Sachs A., Kwak-Kim J., Beaman K.;
RT   "The N-terminal domain of the a2 isoform of vacuolar ATPase can
RT   regulate interleukin-1beta production from mononuclear cells in co-
RT   culture with JEG-3 choriocarcinoma cells.";
RL   Am. J. Reprod. Immunol. 57:201-209(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-695, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [8]
RP   INVOLVEMENT IN ARCL2A, INVOLVEMENT IN WSS, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18157129; DOI=10.1038/ng.2007.45;
RA   Kornak U., Reynders E., Dimopoulou A., van Reeuwijk J., Fischer B.,
RA   Rajab A., Budde B., Nuernberg P., Foulquier F., Dobyns W.B.,
RA   Quelhas D., Vilarinho L., Leao-Teles E., Greally M., Seemanova E.,
RA   Simandlova M., Salih M., Nanda A., Basel-Vanagaite L., Kayserili H.,
RA   Yuksel-Apak M., Larregue M., Vigneron J., Giurgea S., Lefeber D.,
RA   Urban Z., Gruenewald S., Annaert W., Brunner H.G., van Bokhoven H.,
RA   Wevers R., Morava E., Matthijs G., Van Maldergem L., Mundlos S.;
RT   "Impaired glycosylation and cutis laxa caused by mutations in the
RT   vesicular H+-ATPase subunit ATP6V0A2.";
RL   Nat. Genet. 40:32-34(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-695, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   INTERACTION WITH SPAAR.
RX   PubMed=28024296; DOI=10.1038/nature21034;
RA   Matsumoto A., Pasut A., Matsumoto M., Yamashita R., Fung J.,
RA   Monteleone E., Saghatelian A., Nakayama K.I., Clohessy J.G.,
RA   Pandolfi P.P.;
RT   "mTORC1 and muscle regeneration are regulated by the LINC00961-encoded
RT   SPAR polypeptide.";
RL   Nature 541:228-232(2017).
CC   -!- FUNCTION: Part of the proton channel of V-ATPases. Essential
CC       component of the endosomal pH-sensing machinery. May play a role
CC       in maintaining the Golgi functions, such as glycosylation
CC       maturation, by controlling the Golgi pH.
CC       {ECO:0000269|PubMed:16415858, ECO:0000269|PubMed:18157129}.
CC   -!- SUBUNIT: The V-ATPase is a heteromultimeric enzyme composed of at
CC       least thirteen different subunits. It has a membrane peripheral V1
CC       sector for ATP hydrolysis and an integral V0 for proton
CC       translocation. The V1 sector comprises subunits A-H, whereas V0
CC       includes subunits a, d, c, c', and c''. Directly interacts with
CC       PSCD2 through its N-terminal cytosolic tail in an intra-endosomal
CC       acidification-dependent manner (PubMed:16415858). Disruption of
CC       this interaction results in the inhibition of endocytosis
CC       (PubMed:16415858). Interacts with SPAAR (PubMed:28024296).
CC       {ECO:0000269|PubMed:16415858, ECO:0000269|PubMed:28024296}.
CC   -!- INTERACTION:
CC       Q99418:CYTH2; NbExp=2; IntAct=EBI-988630, EBI-448974;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Endosome membrane. Note=In kidney proximal tubules, also detected
CC       in subapical vesicles. {ECO:0000250}.
CC   -!- DISEASE: Cutis laxa, autosomal recessive, 2A (ARCL2A)
CC       [MIM:219200]: A disorder characterized by an excessive congenital
CC       skin wrinkling, a large fontanelle with delayed closure, a typical
CC       facial appearance with downslanting palpebral fissures, a general
CC       connective tissue weakness, and varying degrees of growth and
CC       developmental delay and neurological abnormalities. Some affected
CC       individuals develop seizures and mental deterioration later in
CC       life, whereas the skin phenotype tends to become milder with age.
CC       At the molecular level, an abnormal glycosylation of serum
CC       proteins is observed in many cases. {ECO:0000269|PubMed:18157129}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Wrinkly skin syndrome (WSS) [MIM:278250]: A rare
CC       autosomal recessive disorder characterized by wrinkling of the
CC       skin of the dorsum of the hands and feet, an increased number of
CC       palmar and plantar creases, wrinkled abdominal skin, multiple
CC       musculoskeletal abnormalities, microcephaly, growth failure and
CC       developmental delay. {ECO:0000269|PubMed:18157129}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the V-ATPase 116 kDa subunit family.
CC       {ECO:0000305}.
CC   -!- CAUTION: The N-terminal peptide may increase IL1B secretion by
CC       peripheral blood monocytes; however as this region is probably in
CC       the cytosol, the in vivo relevance of this observation needs to be
CC       confirmed. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF112972; AAD04632.1; -; mRNA.
DR   EMBL; AK289391; BAF82080.1; -; mRNA.
DR   EMBL; CH471054; EAW98434.1; -; Genomic_DNA.
DR   EMBL; BC068531; AAH68531.1; -; mRNA.
DR   CCDS; CCDS9254.1; -.
DR   RefSeq; NP_036595.2; NM_012463.3.
DR   UniGene; Hs.25786; -.
DR   ProteinModelPortal; Q9Y487; -.
DR   BioGrid; 117089; 57.
DR   IntAct; Q9Y487; 5.
DR   STRING; 9606.ENSP00000332247; -.
DR   iPTMnet; Q9Y487; -.
DR   PhosphoSitePlus; Q9Y487; -.
DR   SwissPalm; Q9Y487; -.
DR   BioMuta; ATP6V0A2; -.
DR   DMDM; 172046607; -.
DR   EPD; Q9Y487; -.
DR   MaxQB; Q9Y487; -.
DR   PaxDb; Q9Y487; -.
DR   PeptideAtlas; Q9Y487; -.
DR   PRIDE; Q9Y487; -.
DR   DNASU; 23545; -.
DR   Ensembl; ENST00000330342; ENSP00000332247; ENSG00000185344.
DR   GeneID; 23545; -.
DR   KEGG; hsa:23545; -.
DR   UCSC; uc001ufr.4; human.
DR   CTD; 23545; -.
DR   DisGeNET; 23545; -.
DR   GeneCards; ATP6V0A2; -.
DR   GeneReviews; ATP6V0A2; -.
DR   H-InvDB; HIX0011113; -.
DR   HGNC; HGNC:18481; ATP6V0A2.
DR   HPA; HPA044279; -.
DR   MalaCards; ATP6V0A2; -.
DR   MIM; 219200; phenotype.
DR   MIM; 278250; phenotype.
DR   MIM; 611716; gene.
DR   neXtProt; NX_Q9Y487; -.
DR   OpenTargets; ENSG00000185344; -.
DR   Orphanet; 357074; Autosomal recessive cutis laxa type 2, classic type.
DR   Orphanet; 2834; Wrinkly skin syndrome.
DR   PharmGKB; PA38549; -.
DR   eggNOG; KOG2189; Eukaryota.
DR   eggNOG; COG1269; LUCA.
DR   GeneTree; ENSGT00390000004941; -.
DR   HOGENOM; HOG000037059; -.
DR   HOVERGEN; HBG014606; -.
DR   InParanoid; Q9Y487; -.
DR   KO; K02154; -.
DR   OMA; HPPAEHK; -.
DR   OrthoDB; EOG091G01BI; -.
DR   PhylomeDB; Q9Y487; -.
DR   TreeFam; TF300346; -.
DR   BioCyc; MetaCyc:G66-33375-MONOMER; -.
DR   BRENDA; 3.6.3.6; 2681.
DR   Reactome; R-HSA-1222556; ROS, RNS production in phagocytes.
DR   Reactome; R-HSA-77387; Insulin receptor recycling.
DR   Reactome; R-HSA-917977; Transferrin endocytosis and recycling.
DR   Reactome; R-HSA-983712; Ion channel transport.
DR   ChiTaRS; ATP6V0A2; human.
DR   GeneWiki; ATP6V0A2; -.
DR   GenomeRNAi; 23545; -.
DR   PRO; PR:Q9Y487; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000185344; -.
DR   CleanEx; HS_ATP6V0A2; -.
DR   ExpressionAtlas; Q9Y487; baseline and differential.
DR   Genevisible; Q9Y487; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0016471; C:vacuolar proton-transporting V-type ATPase complex; IBA:GO_Central.
DR   GO; GO:0000220; C:vacuolar proton-transporting V-type ATPase, V0 domain; IEA:InterPro.
DR   GO; GO:0051117; F:ATPase binding; IBA:GO_Central.
DR   GO; GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IBA:GO_Central.
DR   GO; GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro.
DR   GO; GO:0015986; P:ATP synthesis coupled proton transport; IBA:GO_Central.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0090383; P:phagosome acidification; TAS:Reactome.
DR   GO; GO:0016241; P:regulation of macroautophagy; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0033572; P:transferrin transport; TAS:Reactome.
DR   GO; GO:0007035; P:vacuolar acidification; IBA:GO_Central.
DR   GO; GO:0070072; P:vacuolar proton-transporting V-type ATPase complex assembly; IBA:GO_Central.
DR   InterPro; IPR002490; V-ATPase_116kDa_su.
DR   InterPro; IPR026028; V-type_ATPase_116kDa_su_euka.
DR   PANTHER; PTHR11629; PTHR11629; 1.
DR   Pfam; PF01496; V_ATPase_I; 1.
DR   PIRSF; PIRSF001293; ATP6V0A1; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Endosome; Glycoprotein;
KW   Hydrogen ion transport; Ion transport; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    856       V-type proton ATPase 116 kDa subunit a
FT                                isoform 2.
FT                                /FTId=PRO_0000119216.
FT   TOPO_DOM      1    393       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    394    412       Helical. {ECO:0000255}.
FT   TOPO_DOM    413    414       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    415    431       Helical. {ECO:0000255}.
FT   TOPO_DOM    432    445       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    446    475       Helical. {ECO:0000255}.
FT   TOPO_DOM    476    549       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    550    569       Helical. {ECO:0000255}.
FT   TOPO_DOM    570    587       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    588    608       Helical. {ECO:0000255}.
FT   TOPO_DOM    609    651       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    652    671       Helical. {ECO:0000255}.
FT   TOPO_DOM    672    739       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    740    764       Helical. {ECO:0000255}.
FT   TOPO_DOM    765    785       Vacuolar. {ECO:0000255}.
FT   TRANSMEM    786    824       Helical. {ECO:0000255}.
FT   TOPO_DOM    825    856       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     695    695       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     700    700       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15920}.
FT   CARBOHYD    484    484       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    505    505       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     685    685       R -> Q (in dbSNP:rs7969410).
FT                                /FTId=VAR_042730.
FT   VARIANT     813    813       A -> V (in dbSNP:rs17883456).
FT                                /FTId=VAR_042731.
FT   CONFLICT    428    428       L -> W (in Ref. 1; AAD04632).
FT                                {ECO:0000305}.
FT   CONFLICT    669    669       L -> P (in Ref. 2; BAF82080).
FT                                {ECO:0000305}.
SQ   SEQUENCE   856 AA;  98082 MW;  6C38B36FA33A92BA CRC64;
     MGSLFRSETM CLAQLFLQSG TAYECLSALG EKGLVQFRDL NQNVSSFQRK FVGEVKRCEE
     LERILVYLVQ EINRADIPLP EGEASPPAPP LKQVLEMQEQ LQKLEVELRE VTKNKEKLRK
     NLLELIEYTH MLRVTKTFVK RNVEFEPTYE EFPSLESDSL LDYSCMQRLG AKLGFVSGLI
     NQGKVEAFEK MLWRVCKGYT IVSYAELDES LEDPETGEVI KWYVFLISFW GEQIGHKVKK
     ICDCYHCHVY PYPNTAEERR EIQEGLNTRI QDLYTVLHKT EDYLRQVLCK AAESVYSRVI
     QVKKMKAIYH MLNMCSFDVT NKCLIAEVWC PEADLQDLRR ALEEGSRESG ATIPSFMNII
     PTKETPPTRI RTNKFTEGFQ NIVDAYGVGS YREVNPALFT IITFPFLFAV MFGDFGHGFV
     MFLFALLLVL NENHPRLNQS QEIMRMFFNG RYILLLMGLF SVYTGLIYND CFSKSVNLFG
     SGWNVSAMYS SSHPPAEHKK MVLWNDSVVR HNSILQLDPS IPGVFRGPYP LGIDPIWNLA
     TNRLTFLNSF KMKMSVILGI IHMTFGVILG IFNHLHFRKK FNIYLVSIPE LLFMLCIFGY
     LIFMIFYKWL VFSAETSRVA PSILIEFINM FLFPASKTSG LYTGQEYVQR VLLVVTALSV
     PVLFLGKPLF LLWLHNGRSC FGVNRSGYTL IRKDSEEEVS LLGSQDIEEG NHQVEDGCRE
     MACEEFNFGE ILMTQVIHSI EYCLGCISNT ASYLRLWALS LAHAQLSDVL WAMLMRVGLR
     VDTTYGVLLL LPVIALFAVL TIFILLIMEG LSAFLHAIRL HWVEFQNKFY VGAGTKFVPF
     SFSLLSSKFN NDDSVA
//
